Ignite Creation Date:
2024-05-06 @ 4:07 PM
Last Modification Date:
2024-10-26 @ 2:04 PM
Study NCT ID:
NCT04874831
Status:
WITHDRAWN
Last Update Posted:
2021-11-18
First Post:
2021-04-15
Brief Title:
Domatinostat in Combination With Avelumab in Patients With Treatment-naïve Metastatic Merkel Cell Carcinoma MERKLIN 1
Sponsor:
4SC AG
Organization:
4SC AG
Organization Data
Organization:
4SC AG
Class:
INDUSTRY
Study ID:
4SC-202-4-2019
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
4SC AG
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Merck KGaA Darmstadt Germany | INDUSTRY |